Kidswell Bio Corporation
4584.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥13,234,262 | ¥13,239,371 | ¥4,695,465 | ¥4,473,812 |
| - Cash | ¥1,541,503 | ¥2,840,073 | ¥2,995,435 | ¥1,318,255 |
| + Debt | ¥1,134,440 | ¥1,548,700 | ¥1,837,960 | ¥2,033,640 |
| Enterprise Value | ¥12,827,199 | ¥11,947,998 | ¥3,537,990 | ¥5,189,197 |
| Revenue | ¥1,555,585 | ¥1,720,632 | ¥2,045,749 | ¥1,286,393 |
| % Growth | -9.6% | -15.9% | 59% | – |
| Gross Profit | ¥395,526 | ¥597,226 | ¥609,500 | ¥538,290 |
| % Margin | 25.4% | 34.7% | 29.8% | 41.8% |
| EBITDA | -¥80,042 | ¥185,230 | ¥151,196 | ¥116,470 |
| % Margin | -5.1% | 10.8% | 7.4% | 9.1% |
| Net Income | -¥96,543 | ¥157,126 | ¥166,633 | ¥54,021 |
| % Margin | -6.2% | 9.1% | 8.1% | 4.2% |
| EPS Diluted | -1.95 | 3.28 | 3.96 | 1.33 |
| % Growth | -159.5% | -17.2% | 197.7% | – |
| Operating Cash Flow | – | ¥0 | ¥0 | ¥0 |
| Capital Expenditures | – | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | – | ¥0 | ¥0 | ¥0 |